MDT Apr 2024 80.000 put
- CNW Group
Medtronic receives FDA approval for Inceptiv™ closed-loop spinal cord stimulator
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that the U.S. Food and Drug Administration (FDA) has approved the Inceptiv™ closed-loop rechargeable spinal cord stimulator (SCS) for the treatment of chronic pain. Inceptiv is the first Medtronic SCS device to offer a closed-loop feature that senses biological signals along the spinal cord and automatically adjusts stimulation in real time, keeping therapy in harmony with the motions of daily life.
- Insider Monkey
20 Fastest Growing Health Tech Companies in the World
In this article, we will be taking a look at the 20 fastest growing health tech companies in the world. If you do not want to learn about the trends in digital health market, head straight to the 5 Fastest Growing Health tech Companies in the World. Explosive Growth and Key Trends in the Digital […]
- Simply Wall St.
Calculating The Intrinsic Value Of Medtronic plc (NYSE:MDT)
Key Insights The projected fair value for Medtronic is US$100 based on 2 Stage Free Cash Flow to Equity With US$80.38...
